We propose a multi-step model linking the development of HIV dementia with systemic events which occur with the onset of AIDS, and subsequently. We theorize that the Initial critical step is an increase in the trafficking of blood monocytes into the brain parenchyma, and that this is facilitated by the activation of these cells prior to their exit from bone marrow (BM). Specifically, we suggest that events related to either HIV infection within BM, and/or the generalized immune activation which accompanies AIDS, lead to increased production of macrophage colony stimulating factor (M-CSF) within BM which, in turn, leads to induction of CD16 expression on a greater number of the exiting monocytes. Being activated, these cells are primed for transendothelial migration, and hence, can more readily cross the blood-brain barrier. We propose that macrophages themselves, uninfected as well as HIV-infected, are the primary instigators of the neuropathological processes leading to HIV dementia, and that HIV infection within the brain plays a lesser role. Once within the brain parenchyma, the monocytes can produce, as well as elicit from other cells, neurotoxins such as proinflammatory cytokines. Considerable evidence supports this possible outcome. To link the proposed increase in monocyte trafficking into brain with post-entry events and dementia, we propose to characterize the (CD14+) perivascular macrophage population in AIDS brains, with respect to CD16 and HIV expression, and 0-amyloid precursor protein (0-APP)-deposition, the laner being a marker of axonal injury. Based on reports that the alipoprotein E4 allele (apo E4), a known risk factor for Alzheimer's dementia, is also associated with higher levels of circulating CD16+ monocytes, as well as HIV dementia, we will examine this enotype in conjunction with CD16+ monocytes and HIV-associated cognitive impairment. To test our model, we will characterize blood monocytes from HIV-infected patients with and without dementia, followed longitudinally, for activation, proliferation, HIV infection, and surface expression of P-APP. M-CSF levels in cerebrospinal fluid, serum and brain and BM tissues will be determined. Immunostaining will be used to evaluate brain and bone marrow sections for the abundance of CD14, CD16 and HIV expression. To study monocyte trafficking from BM to brain, phylogenetic analyses will be performed using HIV gpl 60 species cloned from uncultured tissues as """"""""tracers."""""""" PCR-based genotyping for apo E will be included. If valid, our model could lead to new approaches for the prevention and treatment of HIV dementia.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH063039-05
Application #
6779104
Study Section
Special Emphasis Panel (ZMH1-NRB-A (02))
Program Officer
Joseph, Jeymohan
Project Start
2000-09-30
Project End
2006-08-31
Budget Start
2004-09-01
Budget End
2006-08-31
Support Year
5
Fiscal Year
2004
Total Cost
$327,000
Indirect Cost
Name
Johns Hopkins University
Department
Neurology
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Gartner, Suzanne; Liu, Yiling; Natesan, Senthilkumar (2012) De novo generation of cells within human nurse macrophages and consequences following HIV-1 infection. PLoS One 7:e40139
Wu, Y; Storey, P; Carrillo, A et al. (2008) Whole brain and localized magnetization transfer measurements are associated with cognitive impairment in patients infected with human immunodeficiency virus. AJNR Am J Neuroradiol 29:140-5
Ragin, A B; Wu, Y; Storey, P et al. (2006) Bone marrow diffusion measures correlate with dementia severity in HIV patients. AJNR Am J Neuroradiol 27:589-92
Burdo, Tricia H; Nonnemacher, Michael; Irish, Bryan P et al. (2004) High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia. DNA Cell Biol 23:261-9
Vehmas, Ari; Lieu, James; Pardo, Carlos A et al. (2004) Amyloid precursor protein expression in circulating monocytes and brain macrophages from patients with HIV-associated cognitive impairment. J Neuroimmunol 157:99-110
Burdo, Tricia H; Gartner, Suzanne; Mauger, David et al. (2004) Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients. J Neurovirol 10 Suppl 1:7-14
Hogan, Tricia H; Stauff, Devin L; Krebs, Fred C et al. (2003) Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression. J Neurovirol 9:55-68